Status:

ACTIVE_NOT_RECRUITING

A Clinical Study on Acuris™ - Conometric Concept for Single Tooth Restoration

Lead Sponsor:

Dentsply Sirona Implants and Consumables

Conditions:

Jaw, Edentulous, Partially

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate the outcome of prosthetic survival of the Acuris conometric concept 1 year after permanent restoration, since this is a new mode of retention using friction fo...

Eligibility Criteria

Inclusion

  • Subject aged between 18-75 years
  • Subject signed and dated the informed consent form
  • In need of an implant replacing a missing tooth in position 17 to 27 or 37 to 47, and each subject can only receive one study implant.
  • Neighbouring tooth to the planned implant must have
  • a natural root or an implant supported restoration mesially
  • a natural root or an implant supported restoration distally Exemption: If the planned implant is in the second molar position, an edentulous space is accepted distally.
  • Presence of natural tooth, partial prosthesis and/or implant supported restoration in the opposite jaw in contact with the planned crown
  • Deemed by the investigator as likely to present an initially stable implant situation

Exclusion

  • Unlikely to be able to comply with study procedures, according to Investigators judgement
  • Subject is not willing to participate in the study or not able to understand the content of the study
  • Involvement in the planning and conduct of the study
  • Severe non-compliance to CIP as judged by the Investigator and/or Dentsply Sirona Implants.
  • Unable or unwilling to return for follow-up visits for a period of five years
  • Simultaneous participation in another clinical study, or former participation in a clinical study during the last 6 months that may interfere with the present study
  • Previous enrolment in the present study
  • Uncontrolled pathological process in the oral cavity
  • Known or suspected current malignancy
  • History of radiation therapy in the head and neck region within 12 months prior to surgery
  • Systemic or local disease or condition that could compromise post-operative healing and/or osseointegration
  • Uncontrolled diabetes mellitus
  • Corticosteroids, iv bisphosphonates or any other medication that could influence post-operative healing and/or osseointegration
  • Current need for major bone grafting and/or augmentation in the planned implant area (minor grafting and soft tissue grafting are allowed)
  • Smoking more than 10 cigarettes per day, present alcohol or drug abuse
  • Known pregnancy at implant installation (Only applicable for sites in United States and Canada)

Key Trial Info

Start Date :

July 30 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2027

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT04063878

Start Date

July 30 2019

End Date

June 30 2027

Last Update

August 24 2025

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

University of Illinois College of Dentistry

Chicago, Illinois, United States, 60612

2

Implant & Prosthodontic Associates

Oklahoma City, Oklahoma, United States, 73142

3

Cholakis Dental Group

Winnipeg, Canada

4

Praxis Prof. Dr. Dhom & Kollegen MVZ GmbH

Ludwigshafen, Germany